Michael Emerman

26.6k total citations · 8 hit papers
149 papers, 17.1k citations indexed

About

Michael Emerman is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Michael Emerman has authored 149 papers receiving a total of 17.1k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Virology, 60 papers in Infectious Diseases and 49 papers in Molecular Biology. Recurrent topics in Michael Emerman's work include HIV Research and Treatment (118 papers), HIV/AIDS drug development and treatment (52 papers) and Cytomegalovirus and herpesvirus research (29 papers). Michael Emerman is often cited by papers focused on HIV Research and Treatment (118 papers), HIV/AIDS drug development and treatment (52 papers) and Cytomegalovirus and herpesvirus research (29 papers). Michael Emerman collaborates with scholars based in United States, South Africa and France. Michael Emerman's co-authors include Harmit S. Malik, Paul F. Lewis, Michael H. Malim, Lily I. Wu, Luc Montagnier, Howard M. Temin, Masahiro Yamashita, Sara L. Sawyer, Keith Peden and Marie A. Vodicka and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Michael Emerman

143 papers receiving 16.8k citations

Hit Papers

Detection of replication-competent and pseudotyped human ... 1987 2026 2000 2013 1992 1987 1994 1993 2002 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene
    1992 857 citations Michael Emerman et al. Journal of Virology profile →
  2. Genome organization and transactivation of the human immunodeficiency virus type 2
    1987 713 citations Michael Emerman et al. Nature profile →
  3. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells.
    1994 705 citations Vineet N. KewalRamani, Michael Emerman et al. profile →
  4. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells
    1993 694 citations Michael Emerman et al. Nature profile →
  5. Visualization of the intracellular behavior of HIV in living cells
    2002 639 citations Michael Emerman et al. profile →
  6. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus
    1994 634 citations Michael Emerman et al. Journal of Virology profile →
  7. Positive selection of primate TRIM5 α identifies a critical species-specific retroviral restriction domain
    2005 534 citations Sara L. Sawyer, Lily I. Wu et al. profile →
  8. Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI
    1991 342 citations Michael Emerman et al. Virology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Emerman United States 67 11.3k 7.4k 6.2k 4.8k 4.0k 149 17.1k
Michael H. Malim United Kingdom 78 15.1k 1.3× 10.7k 1.4× 8.3k 1.3× 7.3k 1.5× 5.7k 1.4× 180 24.3k
Paul D. Bieniasz United States 78 10.6k 0.9× 7.1k 0.9× 6.7k 1.1× 7.1k 1.5× 6.0k 1.5× 183 21.0k
Eric Hunter United States 65 10.1k 0.9× 4.2k 0.6× 5.7k 0.9× 4.1k 0.8× 4.0k 1.0× 297 14.9k
Paul A. Luciw United States 63 8.1k 0.7× 4.5k 0.6× 4.2k 0.7× 4.0k 0.8× 4.4k 1.1× 200 14.3k
John M. Coffin United States 84 12.7k 1.1× 8.1k 1.1× 9.6k 1.5× 4.9k 1.0× 3.8k 0.9× 298 23.3k
Mariano Estéban Spain 67 5.8k 0.5× 5.7k 0.8× 2.6k 0.4× 5.4k 1.1× 5.7k 1.4× 366 15.8k
Reuben S. Harris United States 69 6.9k 0.6× 10.0k 1.3× 3.9k 0.6× 4.1k 0.8× 4.4k 1.1× 237 17.7k
Nathaniel R. Landau United States 57 14.7k 1.3× 6.2k 0.8× 7.4k 1.2× 10.0k 2.1× 4.4k 1.1× 116 21.5k
George N. Pavlakis United States 71 6.0k 0.5× 7.7k 1.0× 3.1k 0.5× 6.0k 1.2× 2.4k 0.6× 248 16.3k
Thomas J. Hope United States 59 5.6k 0.5× 5.9k 0.8× 3.2k 0.5× 3.4k 0.7× 2.5k 0.6× 206 13.2k

Countries citing papers authored by Michael Emerman

Since Specialization
Citations

This map shows the geographic impact of Michael Emerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Emerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Emerman more than expected).

Fields of papers citing papers by Michael Emerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Emerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Emerman. The network helps show where Michael Emerman may publish in the future.

Co-authorship network of co-authors of Michael Emerman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Emerman. A scholar is included among the top collaborators of Michael Emerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Emerman. Michael Emerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tenthorey, Jeannette L., et al.. (2025). Heterozygous and generalist MxA super-restrictors overcome breadth-specificity trade-offs in antiviral restriction. Science Advances. 11(18). eadu0062–eadu0062.
2.
Tenthorey, Jeannette L., et al.. (2025). Indels allow antiviral proteins to evolve functional novelty inaccessible by missense mutations. Cell Genomics. 5(6). 100818–100818.
3.
Li, Yen-Li, et al.. (2025). APOBEC3G Antagonism by Vif, or When Structure Meets Biological and Evolutionary Studies. Annual Review of Virology. 12(1). 451–469. 1 indexed citations
4.
Gray, Carley N, Derek H. Janssens, Jennifer Kirchherr, et al.. (2024). Integrator complex subunit 12 knockout overcomes a transcriptional block to HIV latency reversal. eLife. 13. 1 indexed citations
5.
Li, Yen-Li, Caleigh M. Azumaya, Ignacia Echeverria, et al.. (2023). The structural basis for HIV-1 Vif antagonism of human APOBEC3G. Nature. 615(7953). 728–733. 42 indexed citations
6.
OhAinle, Molly, et al.. (2020). TRIM34 restricts HIV-1 and SIV capsids in a TRIM5α-dependent manner. PLoS Pathogens. 16(4). e1008507–e1008507. 37 indexed citations
7.
Tenthorey, Jeannette L., et al.. (2020). Mutational resilience of antiviral restriction favors primate TRIM5α in host-virus evolutionary arms races. eLife. 9. 21 indexed citations
8.
Graf, Laura, Richard N. McLaughlin, Janet M. Young, et al.. (2019). Combinatorial mutagenesis of rapidly evolving residues yields super-restrictor antiviral proteins. PLoS Biology. 17(10). e3000181–e3000181. 14 indexed citations
9.
Binning, Jennifer M., Nicholas M. Chesarino, Michael Emerman, & John D. Gross. (2019). Structural Basis for a Species-Specific Determinant of an SIV Vif Protein toward Hominid APOBEC3G Antagonism. Cell Host & Microbe. 26(6). 739–747.e4. 13 indexed citations
10.
Emerman, Michael, et al.. (2018). Recurrent Loss of APOBEC3H Activity during Primate Evolution. Journal of Virology. 92(17). 6 indexed citations
11.
Duggal, Nisha K., Wenqing Fu, Joshua M. Akey, & Michael Emerman. (2013). Identification and antiviral activity of common polymorphisms in the APOBEC3 locus in human populations. Virology. 443(2). 329–337. 36 indexed citations
12.
Mitchell, Patrick S., Corinna Patzina, Michael Emerman, et al.. (2012). Evolution-Guided Identification of Antiviral Specificity Determinants in the Broadly Acting Interferon-Induced Innate Immunity Factor MxA. Cell Host & Microbe. 12(4). 598–604. 117 indexed citations
13.
Yamashita, Masahiro & Michael Emerman. (2009). Cellular Restriction Targeting Viral Capsids Perturbs Human Immunodeficiency Virus Type 1 Infection of Nondividing Cells. Journal of Virology. 83(19). 9835–9843. 28 indexed citations
14.
OhAinle, Molly, Julie A. Kerns, Harmit S. Malik, & Michael Emerman. (2006). Adaptive Evolution and Antiviral Activity of the Conserved Mammalian Cytidine Deaminase APOBEC3H. Journal of Virology. 80(8). 3853–3862. 157 indexed citations
15.
Sawyer, Sara L., Lily I. Wu, Joshua M. Akey, Michael Emerman, & Harmit S. Malik. (2006). High-Frequency Persistence of an Impaired Allele of the Retroviral Defense Gene TRIM5α in Humans. Current Biology. 16(1). 95–100. 91 indexed citations
16.
Yamashita, Masahiro & Michael Emerman. (2005). Retroviral infection of non-dividing cells: Old and new perspectives. Virology. 344(1). 88–93. 139 indexed citations
17.
Malim, Michael H. & Michael Emerman. (2001). HIV-1 Sequence Variation. Cell. 104(4). 469–472. 168 indexed citations
18.
Holte, Sarah & Michael Emerman. (2000). A competition model for viral inhibition of host cell proliferation. Mathematical Biosciences. 166(1). 69–84. 3 indexed citations
19.
KewalRamani, Vineet N. & Michael Emerman. (1996). Vpx Association with Mature Core Structures of HIV-2. Virology. 218(1). 159–168. 48 indexed citations
20.
Emerman, Michael & Howard M. Temin. (1986). Quantitative Analysis of Gene Suppression in Integrated Retrovirus Vectors. Molecular and Cellular Biology. 6(3). 792–800. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael H. Malim Breakdown of academic impact, for papers by Paul D. Bieniasz Breakdown of academic impact, for papers by Eric Hunter Breakdown of academic impact, for papers by Paul A. Luciw Breakdown of academic impact, for papers by John M. Coffin Breakdown of academic impact, for papers by Mariano Estéban Breakdown of academic impact, for papers by Reuben S. Harris Breakdown of academic impact, for papers by Nathaniel R. Landau Breakdown of academic impact, for papers by George N. Pavlakis Breakdown of academic impact, for papers by Thomas J. Hope
Rankless by CCL
2026